BASF INDIA LTD. Q1 FY27 Results

BASF India's full-year FY2026 revenue was ₹14,944 Cr (₹149,440M), up marginally from ₹147,803.6M in FY2025. Profit before tax stood at ₹5,612M (~3.75% PBT margin on consolidated). Now, Q1 FY2027 arrives after a significant structural shift: the sale of the Coatings Private Limited subsidiary in June 2026 for ₹230.16 Cr. This unit accounted for a portion of revenue but also carried margin pressure from competitive dynamics in industrial coatings. The exit narrows BASF India's footprint to core chemicals—agrochemicals, performance materials, and functional solutions. Expect Q1 to show this transition: lower absolute revenue (the coatings unit is entirely absent), but potential for margin stabilization if the core business holds pricing and operational leverage.

Strong: Revenue comes in at upper end of ₹3,500–3,600 Cr range, showing resilience in agrochemicals and specialty materials despite macro headwinds. OPM holds 13–14%, signaling that core margin did not compress post-divestment. Working capital trends neutral (DPO stable, DSO controlled), and the divestment is not treated as a significant loss. Guidance for H2 FY27 suggests steady-state run-rate earnings ahead of the agricultural solutions demerger closing. Weak: Revenue misses to lower than ₹3,400 Cr, indicating softer demand in key segments or pricing pressure. OPM compresses to below 12%, signaling either cost inflation or margin-thinning in core chemicals. Working capital absorbs cash (higher receivables, higher inventory), or a significant divestment-related loss/cost emerges. Absence of clarity on the Ag Solutions scheme timing or impact damps sentiment.

BASF India's full-year FY2026 trajectory was stable: revenue up ~1% YoY, PBT steady at ~₹5,600M. The company was in maintenance mode—mature chemical markets, stable margins, focus on capital efficiency. The divestment signals a strategic reset: the Coatings unit was a drag (lower margins, higher competition), and its exit allows BASF to concentrate on higher-margin specialty chemicals and agricultural solutions (pre-demerger). Q1 FY27 is the first print of this leaner profile. If revenue and OPM stay on the run-rate (₹3,400–3,600 Cr, 12–14% OPM), the company remains on track for a steady mid-single-digit earnings trajectory. Risk: if the Ag Solutions demerger creates operational friction or if core margins compress, the reset thesis could be questioned.

FII ownership rose to 5.34% in Q4 FY26, up from 4.12% a year prior—a modest +122 bps inflow. DII ownership is stable at ~6.3–6.4%, and promoters hold steady at 73.33%. The uptick in FII suggests some re-rating appetite, possibly linked to the strategic divestments and cleaner portfolio structure. No signs of promoter pledging or significant insider selling. The steady ownership base and incremental FII accumulation are constructive for sentiment post-result.

BASF delivered a strong recovery in Q1 FY27—PAT grew 162% YoY to ₹360 Cr on volume gains and margin recovery—but management remained cautious on forward visibility. Input cost inflation, geopolitical risks (Middle East), and delayed monsoons create near-term uncertainty; however, capex investments (Cellasto, dispersions) and agricultural demerger position the rump entity for medium-term growth. No quantified guidance provided.

Minimal. Shareholders asked substantive questions (capex plans, demerger timeline, market share, export exposure, capacity utilization, competitive position). Management answered directly on most; deferred on forward capex and detailed market share by segment (competitive sensitivity). No evasion; tone collaborative and transparent. Strong Q&A score reflects willingness to engage.

Score 8/10. Clear, structured, and transparent. Opening presentation covers macro context, FY26 results, Q1 FY27 highlights, strategic initiatives without hype. Extensive Q&A (35+ shareholders) handled directly; no deflection. Explicit disclaimer on forward guidance. Mixed. FY26 execution challenged by input costs (PBT down 9% despite 2% revenue growth); however, Q1 FY27 recovery strong (PAT +162%, OPM 10.5%). Capex execution tracking (Cellasto ahead of schedule, under budget). Demerger on track (99.99% approval, NCLT approval expected end-2026).

BASF India's Q1 FY27 (quarter ended June 30, 2026) consolidated profit for the period surged to ₹360.29 Cr, up 162.2% year-on-year from ₹137.40 Cr and up 423.1% sequentially from a weak ₹68.88 Cr in Q4 FY26. Stripping out the ₹18.15 Cr exceptional gain booked on the sale of BASF India Coatings, adjusted YoY PAT growth is still ~149.0%, confirming the beat is driven by core operations and not the one-off. Revenue from continuing operations (the statement now excludes the divested Coatings business) came in at ₹4,824.26 Cr, up 24.5% YoY over a base of ₹3,874.54 Cr that still included Coatings, and up 40.1% QoQ. Standalone PAT of ₹362.05 Cr is within 0.5% of the consolidated figure, so both bases tell the same story.

The expansion is margin-led: consolidated net margin rose to ~7.5% from 3.5% YoY and 2.0% QoQ, while segment operating margin improved to ~10.8% from 5.5% YoY and 3.2% QoQ. The swing is concentrated in two segments — Materials PBIT flipped from a ₹11.62 Cr loss in Q1 FY26 to a ₹212.69 Cr profit this quarter, and Chemicals PBIT rose to ₹96.12 Cr from ₹16.32 Cr — consistent with a recovery in petrochemical/monomer spreads rather than a volume story. That was partly offset by Agricultural Solutions, whose PBIT fell 53% YoY to ₹77.49 Cr from ₹165.39 Cr, and Nutrition & Care, down to ₹11.06 Cr from ₹20.23 Cr. Agricultural Solutions' QoQ swing (from a ₹19.83 Cr loss to a ₹77.49 Cr profit) is a known seasonal pattern the filing itself flags for that segment, so it should not be read as trend confirmation — the YoY decline is the more telling number.

The stock went into the print at ₹4,091.5, up 12.4% over the past month of trading.

For context: this is the highest quarterly PAT in the last 6 quarters on our records; revenue is at a 6-quarter high.

Against our pre-result preview, the print is a clear beat: the preview flagged revenue of ₹3,400-3,600 Cr, OPM of 12-14%, and PBT margin of 3-4% for the quarter — actual revenue of ₹4,824 Cr and PBT margin of ~10% both surpass those markers, though OPM at ~10.8% lands modestly below the previewed band. Q1 FY27 basic EPS of ₹83.3 alone is already ~98% of the ₹85.10 FY27 full-year consensus EPS the preview cited, implying either this run-rate isn't sustainable for the full year or consensus needs a material upward revision. Management's prior concall (May 2026) offered no quantitative guidance, only qualitative priorities — protecting margins, executing the Celesto and Dispersion Line 3 expansions, and completing the Coatings and Agricultural Solutions portfolio actions; margin protection was not just met but exceeded, though no company press release with management's own framing of this quarter could be extracted from this filing. On the portfolio actions: the Coatings stake sale (100%, ₹230.16 Cr consideration) completed June 30, 2026 and is booked as an exceptional item/discontinued operation this quarter; the Agricultural Solutions demerger cleared its shareholders' meeting on June 24, 2026 but remains subject to further regulatory approvals per the filing notes. Separately, the company disclosed a 14.18% stake acquisition in Clean Max Galapagos the same day as this result, a renewable-energy investment not reflected in this quarter's P&L.